Controller
About the job
- Maintain an active Certified Public Accountant license.
- Have a Bachelor's or Master's degree in Accounting from a top-tier university.
- Have at least 3 years of audit experience at a Big Four or national public accounting firm, with exposure to technology, life sciences, or medical device clients.
- Have at least 8 years of total progressive accounting experience, including at least 3 years as a Controller, Assistant Controller, or equivalent in a venture-backed or private-equity-backed operating company.
- Demonstrate experience drafting ASC 606 revenue recognition memos and other technical accounting position papers accepted by external auditors.
- Have deep working knowledge of United States generally accepted accounting principles, including revenue recognition for multi-element arrangements, inventory costing, leases, and equity.
- Have hands-on experience managing a monthly close and preparing complete financial statements and footnotes.
- Have NetSuite enterprise resource planning experience, ideally as an administrator.
- Have advanced Excel and financial modeling skills and be comfortable building schedules from source data.
- Demonstrate proficiency in using AI tools, including Claude models, and creating projects and artifacts.
- Own the technical accounting file and draft ASC 606 revenue recognition memos for new and amended customer contracts, including performance-obligation identification, standalone selling price allocation, principal-versus-agent analysis, variable consideration, bill-and-hold, and contract asset and liability tracking.
- Author and maintain accounting policy and position papers covering inventory costing and reserves, capitalization thresholds, ASC 842 leases, stock-based compensation, ASC 340-40 contract costs, debt, and convertible instruments in a form suitable for auditor review.
- Research emerging generally accepted accounting principles guidance, assess its impact on the company, and brief leadership on conclusions and required changes.
- Design and document internal controls and accounting procedures for a company preparing for scale, institutional diligence, and potential public-company readiness.
- Administer NetSuite, including the chart of accounts, revenue recognition setup, inventory and material requirements planning configuration, reporting, and management of external NetSuite consultants.
- Own the full accounting cycle, including the general ledger, accounts payable, accounts receivable, revenue and deferred revenue, inventory and cost of goods sold, fixed assets, payroll, accruals, and equity.
- Lead the monthly close, including journal entry review, balance sheet reconciliations, variance analysis, and flux commentary.
- Prepare monthly, quarterly, and annual generally accepted accounting principles financial statements and reporting packages for the Board of Directors, investors, and lenders.
- Maintain revenue schedules, deferred revenue roll-forwards, and inventory reconciliations tied to contract terms and shipping records.
- Serve as the primary liaison for the annual financial statement audit and 401(k) plan audit; plan the audit calendar, prepare prepared-by-client schedules, draft footnotes, and resolve auditor questions with supported positions.
- Coordinate federal and state income tax returns, research and development tax credit studies, Delaware franchise tax, and sales and use tax filings with outside advisors.
- Manage business, insurance, and statistical surveys and maintain compliance with government contracts and grant reporting requirements.
- Lead, coach, and develop the accounting team; set priorities, review work, and build a culture of accuracy and continuous improvement.
- Support the Senior Vice President of Finance on budgeting, reforecasts, customer profitability, pricing, and Board and investor materials.
- Communicate conclusions in plain language to executives and the Board and defend them precisely to auditors and advisors.
- Analyze complex data sets, surface discrepancies, and close the loop on accounting issues.
- Engage proactively with the finance team and cross-functionally with Operations, Commercial, Research and Development, and Human Resources.
- Manage multiple deadlines during close, audit, and Board cycles while maintaining confidentiality and compliance standards.
- Experience with hardware plus software-as-a-service or device plus data-service business models, distributor arrangements, and government- or grant-funded contracts.
- Experience with inventory and manufacturing accounting, including contract manufacturers and standard costing.
- Exposure to fundraising diligence, convertible notes, preferred stock, and cap table administration.
- Experience implementing or optimizing NetSuite modules, including Advanced Revenue Management, material requirements planning, and Fixed Assets.
About the company
BioIntelliSense makes remote patient monitoring possible with its BioButton wearable, which continuously tracks vital signs to support at-home care. The device is designed to be comfortable and discreet, and it sends data to analytics that help clinicians spot early signs of health issues for proactive intervention. It primarily serves hospitals, health systems, provider organizations, and payors in the U.S. and select global markets, selling wearables and providing data analytics services. Its approach centers on cost-effectiveness, ease of use, and healthcare partnerships to improve patient outcomes while reducing costs from hospital stays and emergency care.
Company Size
51-200
Company Stage
Series B
Total Funding
$82M
Headquarters
Golden, Colorado
Founded
2018
Get referred to Biointellisense
See people who can refer or advise you
Simplify's Take
What believers are saying
- Houston Methodist reported a 27% relative mortality reduction in February 2026.
- BioIntelliSense’s February 2025 Hicuity Health partnership expands managed monitoring for hospital-at-home programs.
- FDA clearance of the rechargeable BioButton Multi-Patient in October 2024 unlocks reusable unit economics.
What critics are saying
- Medtronic acquired BioIntelliSense in 2025, ending independent employer upside for applicants.
- Employee count fell from 121 in 2025 to 101 in 2026, signaling contraction.
- Telemetry incumbents and hospital command-center vendors can bundle similar monitoring into existing contracts.
What makes Biointellisense unique
- FDA-cleared BioButton Multi-Patient scales continuous inpatient monitoring across 2,653 Houston Methodist beds.
- BioDashboard combines minute-level biometrics with analytics, reducing manual spot-check nursing workflows.
- iRhythm’s exclusive license for BioIntelliSense patents validates its multiparameter sensor IP.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
HSA and Flexible Spending Accounts
Safe Harbor 401(k) Plan with 3% Employer Contribution with immediate vesting
Flexible Vacation Plans
Sick Leave
11 Company Holidays
Home Office Benefits Stipend
Growth & Insights and Company News
6 month growth
↑ 1%1 year growth
↑ 2%2 year growth
↑ 3%Top 10 Healthcare Devices and Supplies capital raises and investors in the U.S. - november 16th to december 31st, 2025. Several interesting transactions closed in the Healthcare Devices and Supplies sector over the past month. If you would like more info or would like to discuss the capital raising market for your company, please contact me. * Positron, medical technology company that engages in the development, manufacturing, and sales of PET and PET-CT molecular imaging systems for nuclear medicine providers across North America, received $2 million of development capital from investors. * TELA Bio, commercial-stage medical technology that provides innovative soft-tissue reconstruction solutions and optimizes clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy, received $4.65 million of development capital from EW Healthcare Partners and Nantahala Capital Management. * Alerje, health technology solution for individuals with severe food allergies, was acquired by SemPresto. * Applied Tissue Technologies, wound care technologies that offer treatment of common acute and chronic wounds, was acquired by New Horizon Medical Solutions. * BioIntelliSense, remote patient monitoring device that enhances healthcare delivery, raised $58.05 million of venture funding. * eLux Medical, fat removal technology that disrupts the cosmetic surgery market, raised $11.28 million through a combination of Series B and Series B-1 venture funding from investors, putting the company's pre-money valuation at $12 million. * Entirety Biomedical, high-performance absorbable metal implants that improve the quality of life with advanced bioabsorbable implant technology, raised $1.2 million of venture funding in a deal led by NuFund Venture Group, putting the company's pre-money valuation at $8.8 million. * OrthoPreserve, meniscus implant device that replaces the damaged meniscus to relieve pain, restore mobility, and prevent the accelerated arthritis development that normally accompanies a meniscectomy, raised $157,000 of venture funding in the form of convertible debt financing from investors. * RedDrop Dx, device that allows blood collection to be done quickly, painlessly, and without a trained professional, raised $7 million of seed funding in a deal led by Phase Three Product Development, Stout Street Capital and Innosphere Ventures Fund. * TYBR Health, collagen-based resorbable hydrogel that protects healing tendons and ligaments and support recovery after surgery, raised $7.14 million through a combination of Seed Prime-1 and Seed Prime-2 funding from Johnson & Johnson Innovation - JLABS, Texas Medical Center and VentureSouq, putting the company's pre-money valuation at $9.66 million. Tamara williams. Managing director. Please contact me if you have any questions or would like to discuss your capital raise:
- BioIntelliSense's FDA-cleared BioButton(R) wearable and BioDashboard(TM) clinical intelligence system will integrate with Hicuity Health's 24/7 virtual patient monitoring services.
What You Should Know:– BioIntelliSense, a leader in continuous health monitoring and clinical intelligence, and Hicuity Health, a leading provider of tech-enabled virtual care services, today announced a strategic partnership to offer fully managed, end-to-end continuous patient monitoring to hospitals and health systems.– This partnership addresses critical infrastructure and staffing challenges faced by hospitals and health systems, empowering them to deploy proven, scalable monitoring solutions for in-hospital care, hospital-at-home programs, post-hospital discharge and chronic remote care management.BioIntelliSense and Hicuity Health Partner to Enhance Continuous Patient MonitoringBioIntelliSense is transforming continuous health monitoring and clinical intelligence for virtual care and remote patient monitoring (RPM) across in-hospital and home settings. Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multiparameter vital signs and physiological biometrics, offering an effortless user experience. The FDA-cleared BioButton® wearable, BioHub® gateways, BioMobile™ applications, BioCloud™ data services, and BioDashboard™ clinical intelligence system together create a scalable, reliable solution for continuous patient monitoring. AI-driven analytics provide clinicians with high-resolution patient trends and data-driven insights, enabling improved and safer care.Strategic Partnership with Hicuity Health· BioIntelliSense’s FDA-cleared BioButton® wearable and BioDashboard™ clinical intelligence system will integrate with Hicuity Health’s 24/7 virtual patient monitoring services.· This integration provides nurses and clinicians with actionable health insights and improved workflow efficiencies.· Hicuity Health’s services, delivering over 11 million hours of patient monitoring annually, reduce workforce burden and enhance high-acuity patient care.Advancing Scalable Continuous Care· “The combination of BioIntelliSense’s award-winning, medical-grade solution with Hicuity Health’s expertise ensures that health systems of all sizes can deploy and scale continuous care programs efficiently,” said James Mault, MD, CEO and Founder of BioIntelliSense.· The partnership addresses staffing challenges in health systems by providing a comprehensive, technology-enabled solution that enables earlier interventions, improves patient outcomes, and optimizes clinical resource utilization.Enhanced Virtual Care Capabilities· The rechargeable, wireless BioButton® wearable continuously and passively monitors patient vital signs and biometrics, automating 1,440 measurements per patient per day.· The BioDashboard clinical intelligence engine utilizes algorithmic-based analytics to track vital sign trends, securely monitored by Hicuity Health.· Hicuity Health’s clinical teams follow predefined workflows and escalation protocols in collaboration with health systems to ensure timely interventions and better patient outcomes.This collaboration offers hospitals and health systems an effective solution to initiate or expand their virtual care programs, enhancing efficiency, scalability, and patient care quality
iRhythm Technologies announced that the company has signed an exclusive license agreement with BioIntelliSense, a continuous health monitoring and clinical intelligence company, to develop and commercialize certain patented technology assets within ambulatory cardiac monitoring, ACM.
iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company has signed an exclusive license agreement with BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, to develop and commercialize certain patented technology assets within ambulatory cardiac monitoring (ACM).